Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexagene Holdings Inc V.LXG


Primary Symbol: LXXGQ

Healthcare Medical Devices
Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.


GREY:LXXGQ - Post by User

Lexagene Holdings Inc > Quality management, quality technology, perfect timing
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(159)
•••
Comment by TanzaniteMotherLodeon Nov 02, 2020 2:21pm
39 Views
Post# 31823863

RE:RE:RE:RE:RE:RE:RE:Quality management, quality technology, perfect timing

RE:RE:RE:RE:RE:RE:RE:Quality management, quality technology, perfect timingShows how much you know..............COVID19 is one of many markets for LEXAGENE.......we got vets, we got food safety, we got water testing, we got open access, we are good for antibiotic resistance, we got flu, we got other viruses you big dumb fvck,,,,,,,,,,,,,keep shorting you POS


letsdoit wrote: Exactly my point Dave, it's gonna take years and years to ramp up production, by which time Covid will be a distant memory, So, I, for one, am certainly taking all this "Covid opportunity " with not just a pinch of salt but a shovel load of salt, getting FDA approval (if they get it) will spike up the SP and that will hopefully give me my money back so I can get out, otherwise I'll be touching a hundred years of age before they make a real profit


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities